Novartis announced Nov. 19 that it will become the first pharmaceutical company to achieve 100% renewable electricity in its European operations through VPPAs following the completion of five such agreements with three developers.

The pharmaceutical company signed five VPPAs that collectively add more than 275 MW of renewable energy to the grid. The agreements will lead to the generation of wind and solar power through six projects across Spain developed by three different providers: Acciona, EDP Renewables and Enel Green Power…

Click here to view the full article.